In its research, the Biozentrum incorporates the benefits of being international, interdisciplinary and innovative along with having leading-edge technology and highly qualified and motivated employees.

The Biozentrum of the University of Basel is one of the worldwide leading institutes for molecular and biomedical basic research and teaching.

In the training of top qualified scientists for the future to work in universities, industry and the community, the Biozentrum emphasizes a strong research orientation and the close guidance of its students.

Richard Neher wins the Open Science Prize

Prof. Richard Neher from the Biozentrum of the University of Basel is the joint winner of the Open Science Prize, together with Prof. Trevor Bedford of the Fred Hutchinson Cancer Research Center in Seattle. The two scientists have been awarded the prize for their open access online tool “nextstrain.org”, which allows the real-time tracking of the... more

Michael N. Hall awarded Cancer Research Prize

On February 8th, 2017, the American National Foundation for Cancer Research announced that Michael N. Hall, Professor of Biochemistry at the Biozentrum of the University of Basel, has been selected as the winner of the 2017 Szent-Györgyi Prize for Progress in Cancer Research. The award recognizes his groundbreaking discovery of the protein kinase... more

Not necessarily harmful: Protein aggregates in the brain

Protein aggregates in neurons are characteristic for Alzheimer's, Parkinson's and other neurodegenerative diseases. These so-called amyloids arise from misfolded proteins and lead to cell death. The team headed by Prof. Martin Spiess at the Biozentrum of the University of Basel has demonstrated by the example of the hormone vasopressin that such... more